<--- Back to Details
First PageDocument Content
Investment / Stock market / Types of business entity / Mergers and acquisitions / Tender offer / Finance / Tel Aviv Stock Exchange / Israel Securities Authority / Public company / Corporate finance / Financial economics / Business
Date: 2008-06-04 14:15:31
Investment
Stock market
Types of business entity
Mergers and acquisitions
Tender offer
Finance
Tel Aviv Stock Exchange
Israel Securities Authority
Public company
Corporate finance
Financial economics
Business

Request for exemptive relief fiom the provisions of Rule 14d-7(a)(l) and no-action relief under the provisions of Rule 14e-1(c) promulgated under the Securities Exchange Act of 1934, as amended

Add to Reading List

Source URL: www.sec.gov

Download Document from Source Website

File Size: 917,92 KB

Share Document on Facebook

Similar Documents

SECURITY REFERENCE FILE www.exchange-data.com Version 2.5 October 2015  Security Reference File

SECURITY REFERENCE FILE www.exchange-data.com Version 2.5 October 2015 Security Reference File

DocID: 1oN2C - View Document

IMPORTANT NOTE This document is an unofficial translation of the Hebrew original, March 31, 2012 financial report of CanFite BioPharma Ltd. that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securities Aut

IMPORTANT NOTE This document is an unofficial translation of the Hebrew original, March 31, 2012 financial report of CanFite BioPharma Ltd. that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securities Aut

DocID: 1lsbL - View Document

IMPORTANT NOTE This document is an unofficial translation of the Hebrew original, June 30, 2012 financial report of Can-Fite BioPharma Ltd. that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securities Aut

IMPORTANT NOTE This document is an unofficial translation of the Hebrew original, June 30, 2012 financial report of Can-Fite BioPharma Ltd. that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securities Aut

DocID: 1lpWw - View Document

IMPORTANT NOTE This document is an unofficial translation of the Hebrew original, September 30, 2012 financial report of Can-Fite BioPharma Ltd. that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securitie

IMPORTANT NOTE This document is an unofficial translation of the Hebrew original, September 30, 2012 financial report of Can-Fite BioPharma Ltd. that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securitie

DocID: 1lcTd - View Document

Foreign Exposure through Domestic Equities Fang Caia , Francis E. Warnockb,c,d a b

Foreign Exposure through Domestic Equities Fang Caia , Francis E. Warnockb,c,d a b

DocID: 1fJO8 - View Document